DNA methylation signatures of bilateral hippocampal volume, asymmetry and atrophy: a cross-omics analysis in the general population
BACKGROUND: Left-right hippocampal volumetric asymmetry and atrophy are implicated in neurodegenerative and neuropsychiatric disorders, yet their molecular basis in healthy adults remains poorly understood. METHODS: We conducted a meta-analysis of epigenome-wide association studies across six population-based cohorts (n = 8156; 53% women; mean age = 60.7 years) to identify DNA methylation signatures associated with left and right hippocampal volumes (LHCV, RHCV) and hippocampal asymmetry (i.e, differences between left and right volumes divided by their sums). FINDINGS: We identified five CpGs and 262 differentially methylated regions associated with LHCV, nine CpGs and 246 regions with RHCV, one CpG and 16 regions with asymmetry. Cross-omics integration uncovered 15 LHCV-related and 13 RHCV-related methylation-gene expression pairs, with five overlapping genes primarily involved in immune regulation. LHCV-specific genes were involved in cellular signalling, and Mendelian randomisation (MR) analyses supported a potential causal association between brain expression of DIP2C and increased risk of major depressive disorder. RHCV-specific genes were involved in neuronal differentiation pathways, with MR analyses suggesting that brain-tissue expression of BAIAP2, MACF1, SLC16A5, and CORO1B was associated with neuropsychiatric disorders. We also identified sex-specific patterns with hippocampal asymmetry. Notably, baseline methylation at these sites predicted hippocampal atrophy rates, explaining >10% of the variation. Associations with multiple healthy dietary patterns suggest modifiable influences on hippocampal structure. INTERPRETATION: These findings highlight distinct methylation profiles as potential biomarkers or therapeutic targets for neuropsychiatric and neurodegenerative conditions. FUNDING: Institutional funds, Federal Ministry of Education and Research of Germany, Alzheimer's Association.
Authors
- Karen A. Mather (ORCID: https://orcid.org/0000-0003-4143-8941)
- Dina Vojinović (ORCID: https://orcid.org/0000-0001-5744-0232)
- Santiago Estrada (ORCID: https://orcid.org/0000-0003-0339-8870)
- Monique M.B. Breteler (ORCID: https://orcid.org/0000-0002-0626-9305)
- Nicola J. Armstrong (ORCID: https://orcid.org/0000-0002-4477-293X)
- Katharina Wittfeld (ORCID: https://orcid.org/0000-0003-4383-5043)
- Natalie A. Royle
- Valentina Talevi (ORCID: https://orcid.org/0000-0003-4418-7439)
- Konstantinos Melas (ORCID: https://orcid.org/0009-0000-5206-5322)
- Hans Jörgen Grabe
- Joanna M. Wardlaw
- Mohammed A. Imtiaz
- Juliana Petri Tavares
- Dan Liu (ORCID: https://orcid.org/0009-0009-6407-1055)
- Marian Beekman
- Henry Völzke
- Simon R. Cox
- Ruiqi Wang
- Qiong Yang
- Alexander Teumer
- Perminder S. Sachdev (ORCID: https://orcid.org/0000-0002-9595-3220)
- Robert F. Hillary
- N. Ahmad Aziz (ORCID: https://orcid.org/0000-0001-6184-458X)
- P. Eline Slagboom
- Robin Bülow
- Wei Wen
Institutions
- Boston University (US)
- New South Wales Department of Health (AU)
- NHS Lothian (GB)
- Curtin University (AU)
- Universitätsmedizin Greifswald (DE)
- Leiden University Medical Center (NL)
- German Center for Neurodegenerative Diseases (DE)
- UNSW Sydney (AU)
- Framingham Heart Study (US)
- Max Planck Institute for Biology of Ageing (DE)
- University of Edinburgh (GB)
Publication Details
- Journal
- EBioMedicine
- Published
- 2026-05-11
- DOI
- https://doi.org/10.1016/j.ebiom.2026.106289
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Alzheimer's Association
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung